IGF-1 injection safety study in healthy adults
This study tests a new injection called GenSci155 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, so participants will be closely monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must be in good general health, with no major medical conditions.
- Your body mass index (BMI) must be between 19 and 28.
- You must not have used any IGF-1 medications recently.
- You must be willing to use birth control (if applicable) and avoid pregnancy or sperm donation for 3 months after the last dose.
- You must not have certain infections (like hepatitis or HIV) or recent major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests a new drug called GenSci120, given as multiple injections under the skin, to see if it is safe in healthy adults. It will also measure how the drug moves through the body and how it affects certain immune markers.
Hear when a new Healthy Adult Trial Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.